Iowa House File 213 (HF213) is a bill introduced on February 6, 2025, aimed at regulating pharmacy benefit managers (PBMs), pharmacies, and prescription drug benefits. The bill seeks to establish guidelines and oversight for PBMs to ensure fair practices in the management of prescription drug benefits, aiming to protect pharmacies and consumers from potentially unfair practices.
Positive media analysis is being generated.
Although direct media critiques of HF213 are not found, opposition to similar bills often comes from PBMs and insurance companies. They contend that increased regulation could lead to higher administrative costs and potentially reduce the negotiating power that helps keep drug prices lower for consumers.
About This Analysis
This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the Iowa General Assembly. Conflict-of-interest analysis for this bill is coming soon.
IA HF213